Podchaser Logo
Home
Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSCLC and beyond | S4E1

Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSCLC and beyond | S4E1

Released Tuesday, 25th June 2024
Good episode? Give it some love!
Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSCLC and beyond | S4E1

Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSCLC and beyond | S4E1

Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSCLC and beyond | S4E1

Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSCLC and beyond | S4E1

Tuesday, 25th June 2024
Good episode? Give it some love!
Rate Episode

Dr. Jamie L. Schneider, delves into the practical considerations for targeted therapy in ALK-rearranged non-small cell lung cancer (NSCLC) through an engaging patient case commentary.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features